BRPI0906261A2 - "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente" - Google Patents
"métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente"Info
- Publication number
- BRPI0906261A2 BRPI0906261A2 BRPI0906261-0A BRPI0906261A BRPI0906261A2 BR PI0906261 A2 BRPI0906261 A2 BR PI0906261A2 BR PI0906261 A BRPI0906261 A BR PI0906261A BR PI0906261 A2 BRPI0906261 A2 BR PI0906261A2
- Authority
- BR
- Brazil
- Prior art keywords
- patient sample
- asthma subtype
- diagnosing
- methods
- therapeutic agent
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title 2
- 239000013610 patient sample Substances 0.000 title 2
- 238000009007 Diagnostic Kit Methods 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7257208P | 2008-03-31 | 2008-03-31 | |
| US4148008P | 2008-04-01 | 2008-04-01 | |
| US12838308P | 2008-05-20 | 2008-05-20 | |
| US20539209P | 2009-01-16 | 2009-01-16 | |
| PCT/US2009/039033 WO2009124090A1 (en) | 2008-03-31 | 2009-03-31 | Compositions and methods for treating and diagnosing asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0906261A2 true BRPI0906261A2 (pt) | 2015-07-07 |
Family
ID=40695508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0906261-0A BRPI0906261A2 (pt) | 2008-03-31 | 2009-03-31 | "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente" |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110123530A1 (pt) |
| EP (2) | EP2631302A3 (pt) |
| JP (3) | JP6161233B2 (pt) |
| KR (2) | KR102070761B1 (pt) |
| CN (2) | CN102232113A (pt) |
| AU (1) | AU2009231733B2 (pt) |
| BR (1) | BRPI0906261A2 (pt) |
| CA (1) | CA2718120A1 (pt) |
| IL (1) | IL208366A0 (pt) |
| MX (1) | MX348362B (pt) |
| NZ (2) | NZ588853A (pt) |
| PH (1) | PH12018500045A1 (pt) |
| RU (2) | RU2607569C2 (pt) |
| SG (1) | SG2014014138A (pt) |
| WO (1) | WO2009124090A1 (pt) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7291331B1 (en) | 2002-09-11 | 2007-11-06 | La Jolla Institute For Allergy And Immunology | Methods of treating OX40 medicated recall immune responses |
| PL3718564T3 (pl) | 2003-12-23 | 2024-03-18 | Genentech, Inc. | Nowe przeciwciała anty-IL 13 i ich zastosowania |
| BRPI1016061A2 (pt) | 2009-05-28 | 2016-09-13 | Glaxo Group Ltd | "proteína de ligação de antígeno, célula hospedeira transfectada ou transformada recombinante, composição farmacêutica, método de tratamento de um paciente humano, uso de uma proteína de ligação de antígeno, método para a redução da agregação de um domínio variável simples de imunoglobulina, vk dab humano derivado de uma estrutura da linha germinativa, e, domínio variável simples de imunoglobulina." |
| KR101135173B1 (ko) | 2010-01-19 | 2012-04-16 | 한국생명공학연구원 | Ｓｈ３ｒｆ２ 발현 또는 활성 억제제를 함유하는 암의 예방 또는 치료용 조성물 |
| KR101180879B1 (ko) | 2010-06-21 | 2012-09-07 | 중앙대학교 산학협력단 | 천식 진단용 유전자 마커 및 이를 이용한 천식 진단에 필요한 정보를 제공하는 방법 |
| KR101366612B1 (ko) | 2010-10-12 | 2014-02-25 | 한국생명공학연구원 | 시스타틴 ｃ를 유효성분으로 함유하는 천식 예방 및 치료용 조성물 |
| RU2578468C2 (ru) | 2010-12-16 | 2016-03-27 | Дженентек, Инк. | Способы диагностики и лечения, связанные с ингибированием th2 |
| AU2013204900B2 (en) * | 2010-12-16 | 2016-11-10 | Genentech, Inc. | Diagnosis and treatments relating to TH2 inhibition |
| WO2012178188A2 (en) * | 2011-06-23 | 2012-12-27 | Children's Hospital Medical Center | Molecular diagnostic panel of eosinophilic gastrointestinal disorders |
| US9732151B2 (en) * | 2011-11-03 | 2017-08-15 | Merck Sharp & Dohme Corp. | Biomarkers for TSLP treatment |
| JP6192122B2 (ja) * | 2012-01-09 | 2017-09-06 | スージョウ マイクロダイアグ バイオメディスン カンパニー リミテッド | 結腸直腸癌診断および予測のためのバイオマーカー |
| CN107099581B (zh) * | 2012-03-27 | 2021-07-13 | 弗·哈夫曼-拉罗切有限公司 | 预测、诊断和治疗特发性肺纤维化的方法 |
| AR091069A1 (es) | 2012-05-18 | 2014-12-30 | Amgen Inc | Proteinas de union a antigeno dirigidas contra el receptor st2 |
| EP2708898A1 (de) | 2012-09-14 | 2014-03-19 | Sterna Biologicals GmbH & Co. Kg | Verfahren zur Diagnose eines molekularen Phänotyps eines an einer mit chronischen Entzündungen einhergehenden Erkrankung leidenden Patienten |
| US10132809B2 (en) | 2012-10-10 | 2018-11-20 | Rhote Island Hospital | Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis |
| DK3199552T3 (da) | 2012-11-20 | 2020-03-30 | Sanofi Sa | Anti-ceacam5-antistoffer og anvendelser heraf |
| EP2931920B1 (en) * | 2012-12-14 | 2018-03-07 | The University of Newcastle | Biomarkers of asthma inflammatory phenotypes and response to therapy |
| EP2968454B1 (en) * | 2013-03-15 | 2019-02-13 | Regeneron Pharmaceuticals, Inc. | Il-33 antagonists and uses thereof |
| WO2015009996A1 (en) * | 2013-07-19 | 2015-01-22 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating eosinophilic esophagitis |
| CN120904322A (zh) | 2013-09-13 | 2025-11-07 | 豪夫迈·罗氏有限公司 | 包含纯化的重组多肽的方法和组合物 |
| RU2016107435A (ru) | 2013-09-13 | 2017-10-18 | Дженентек, Инк. | Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты |
| US20160304866A1 (en) * | 2013-09-27 | 2016-10-20 | Aqua Therapeutics Co., Ltd. | Drug for Disease Caused by Expression of Periostin Except Eye Disease, and Use Thereof |
| AR098155A1 (es) * | 2013-10-23 | 2016-05-04 | Genentech Inc | Métodos para diagnosticar y tratar trastornos eosinofílicos |
| CA2937387A1 (en) | 2014-01-27 | 2015-07-30 | Medimmune, Llc | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
| CN103792375B (zh) * | 2014-01-29 | 2017-07-07 | 华中科技大学同济医学院附属同济医院 | 外周血白细胞介素25水平在哮喘分型中的应用及分型方法 |
| HK1232290A1 (zh) | 2014-02-07 | 2018-01-05 | Medimmune, Llc | 检测人类骨膜蛋白的新型测定 |
| WO2015126750A1 (en) * | 2014-02-19 | 2015-08-27 | Array Biopharma Inc. | BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO TREATMENT WITH A CRTh2 INHIBITOR |
| UA117608C2 (uk) | 2014-02-21 | 2018-08-27 | Дженентек, Інк. | Спосіб лікування еозинофільного захворювання у пацієнта шляхом застосування біспецифічного анти-il-13/il-17 антитіла |
| JP7231326B2 (ja) * | 2014-11-10 | 2023-03-01 | ジェネンテック， インコーポレイテッド | Ｉｌ－３３媒介性障害のための治療及び診断方法 |
| AU2016205188A1 (en) | 2015-01-09 | 2017-06-22 | Medimmune, Llc | Assay to detect human DPP-4 |
| MX2017011486A (es) | 2015-03-16 | 2018-06-15 | Genentech Inc | Métodos de detección y cuantificación de il-13 y sus usos en el diagnóstico y tratamiento de enfermedades asociadas a th2. |
| HRP20210650T1 (hr) | 2015-09-09 | 2021-05-28 | Novartis Ag | Protutijela koja vežu timusni stromalni limfopoetin (tslp) i postupci uporabe protutijela |
| EA038332B1 (ru) | 2015-09-09 | 2021-08-10 | Новартис Аг | Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул |
| EP3371225A2 (en) | 2015-11-04 | 2018-09-12 | AstraZeneca AB | Dipeptidyl peptidase-4 and periostin as predictors of clinical response to eosinophil-targeted therapeutic agents in eosinophilic diseases |
| JP6531629B2 (ja) * | 2015-11-17 | 2019-06-19 | 株式会社ダイフク | 物品搬送設備 |
| WO2017123401A1 (en) | 2016-01-13 | 2017-07-20 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| EP3417079A4 (en) * | 2016-02-17 | 2019-07-10 | Icahn School of Medicine at Mount Sinai | NASAL BIOMARKERS FOR ASTHMA |
| WO2017147492A1 (en) * | 2016-02-26 | 2017-08-31 | National Jewish Health | Methods of detecting and treating airway inflammatory diseases |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| MX2018013038A (es) | 2016-04-27 | 2019-03-28 | Pfizer | Anticuerpos anti-il-33, composiciones, metodos y usos de los mismos. |
| TW201842933A (zh) * | 2017-05-05 | 2018-12-16 | 瑞士商諾華公司 | 使用il-17拮抗劑選擇性治療氣喘的方法 |
| KR101967826B1 (ko) * | 2017-06-30 | 2019-04-11 | 아주대학교산학협력단 | 페리오스틴을 이용한 아이소사이아네이트 직업성 천식의 진단방법 |
| ES2753602R1 (es) * | 2017-07-19 | 2020-05-20 | Fundacion Instituto De Investig Sanitaria Fundacion Jimenez Diaz | Biomarcadores diferenciales de asma |
| ES2697299B2 (es) * | 2017-07-19 | 2020-04-15 | Fundacion Instituto De Investig Sanitaria Fundacion Jimenez Diaz | Biomarcadores diferenciales de asma |
| CN109161590B (zh) * | 2017-08-23 | 2022-03-18 | 中南大学 | 整合素β4基因DNA甲基化位点在制备哮喘和或COPD早期诊断的生物标志物的应用 |
| CN107643405B (zh) * | 2017-09-19 | 2020-07-17 | 上海市肺科医院 | 一种基于自身抗体检测的肺癌诊断试剂盒及其应用 |
| US11859250B1 (en) | 2018-02-23 | 2024-01-02 | Children's Hospital Medical Center | Methods for treating eosinophilic esophagitis |
| EP3781588B1 (en) | 2018-04-20 | 2024-10-30 | Children's Hospital Medical Center | Blood biomarker for eosinophilic gastrointestinal disorders |
| CN108977511A (zh) * | 2018-07-03 | 2018-12-11 | 张罗 | 检测鼻腔脱落细胞中cst1基因表达量的方法及应用 |
| WO2020007227A1 (zh) * | 2018-07-03 | 2020-01-09 | 首都医科大学附属北京同仁医院 | 检测慢性鼻窦炎伴鼻息肉亚型的方法和试剂盒及alox15基因作为生物标志物的应用 |
| CN108913764A (zh) * | 2018-07-03 | 2018-11-30 | 张罗 | 检测鼻腔脱落细胞中alox15基因表达量的方法及应用 |
| EP3599285A1 (en) | 2018-07-25 | 2020-01-29 | Rheinische Friedrich-Wilhelms-Universität Bonn | Method of diagnosing asthma subtypes |
| CN109439744A (zh) * | 2018-12-24 | 2019-03-08 | 常州市第二人民医院 | 重症哮喘诊断用分子标志物 |
| CN110746507B (zh) | 2018-12-25 | 2020-06-26 | 江苏荃信生物医药有限公司 | 抗人白介素4受体α单克隆抗体及其应用 |
| US12297501B2 (en) | 2019-02-25 | 2025-05-13 | Children's Hospital Medical Center | Methods for diagnosing and treating eosinophilic gastritis |
| US20220146500A1 (en) * | 2019-02-27 | 2022-05-12 | Yale University | Compositions and methods for enhancing mucosal immunity |
| CN110672858A (zh) * | 2019-10-18 | 2020-01-10 | 郑湘榕 | 一种检测试剂盒在制备用于婴幼儿喘息性疾病的检测试剂盒中的应用 |
| CN111690061B (zh) * | 2020-06-28 | 2022-08-23 | 中国人民解放军东部战区疾病预防控制中心 | 人源化抗鼠疫耶尔森菌抗原f1的抗体及应用 |
| CA3185192A1 (en) * | 2020-07-10 | 2022-01-13 | Sujun DENG | Anti-ige engineered antibody and application thereof |
| JP2022061491A (ja) * | 2020-10-06 | 2022-04-18 | 国立大学法人福井大学 | 慢性副鼻腔炎の患者を分類するためのデータの取得方法、およびその利用 |
| AU2021379882A1 (en) | 2020-11-10 | 2023-06-29 | Sanofi | Ceacam5 antibody-drug conjugate formulation |
| EP4636780A1 (en) | 2022-12-16 | 2025-10-22 | Yamaguchi University | Asthmatic disease condition estimation server, asthmatic disease condition estimation program, and asthmatic disease condition estimation method |
| KR20250017928A (ko) * | 2023-07-28 | 2025-02-04 | 재단법인 아산사회복지재단 | 객담 단백체를 이용한 생물학적 제제에 대한 천식 치료 반응성 예측을 위한 바이오마커 및 이의 용도 |
| CN119464499A (zh) * | 2024-12-16 | 2025-02-18 | 杭州泰合仁生物技术有限公司 | Alox15作为肺腺癌的生物标志物及应用 |
Family Cites Families (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4578349A (en) * | 1982-04-08 | 1986-03-25 | Abbott Laboratories | Immunoassay for carcinoembryonic antigen (CEA) |
| US4818709A (en) * | 1983-01-21 | 1989-04-04 | Primus Frederick J | CEA-family antigens, Anti-CEA antibodies and CEA immunoassay |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4737456A (en) * | 1985-05-09 | 1988-04-12 | Syntex (U.S.A.) Inc. | Reducing interference in ligand-receptor binding assays |
| US4676980A (en) * | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US6548640B1 (en) * | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5231009A (en) * | 1986-08-13 | 1993-07-27 | Molecular Diagnostics, Inc. | Cdnas coding for members of the carcinoembryonic antigen family |
| US6022958A (en) * | 1986-08-13 | 2000-02-08 | Bayer Corporation | cDNAs coding for members of the carcinoembryonic antigen family |
| US5122599A (en) * | 1986-08-13 | 1992-06-16 | Molecular Diagnostics, Inc. | CDNAS coding for members of the carcinoembryonic antigen family |
| IL85035A0 (en) * | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| JP3101690B2 (ja) * | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| US5606040A (en) * | 1987-10-30 | 1997-02-25 | American Cyanamid Company | Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group |
| US5770701A (en) * | 1987-10-30 | 1998-06-23 | American Cyanamid Company | Process for preparing targeted forms of methyltrithio antitumor agents |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| EP0368684B2 (en) * | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5413923A (en) | 1989-07-25 | 1995-05-09 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
| US5208020A (en) * | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5959177A (en) * | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6075181A (en) * | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5814318A (en) | 1990-08-29 | 1998-09-29 | Genpharm International Inc. | Transgenic non-human animals for producing heterologous antibodies |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| US5770429A (en) * | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| CA2095633C (en) * | 1990-12-03 | 2003-02-04 | Lisa J. Garrard | Enrichment method for variant proteins with altered binding properties |
| US7018809B1 (en) * | 1991-09-19 | 2006-03-28 | Genentech, Inc. | Expression of functional antibody fragments |
| PT1024191E (pt) | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
| JPH05268982A (ja) * | 1992-03-27 | 1993-10-19 | Hoechst Japan Ltd | 骨形成作用を有する新規な蛋白質およびその製造法 |
| DK0598877T3 (da) | 1992-06-09 | 2000-02-21 | Hoppe Ag | Falle og dørlås |
| US5596072A (en) * | 1992-08-21 | 1997-01-21 | Schering Corporation | Method of refolding human IL-13 |
| US5635483A (en) * | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US5780588A (en) * | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| WO1995011923A1 (en) * | 1993-10-29 | 1995-05-04 | Dana-Farber Cancer Institute, Inc. | A novel tumor marker and novel method of isolating same |
| US5773001A (en) * | 1994-06-03 | 1998-06-30 | American Cyanamid Company | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
| DE69535316T2 (de) * | 1994-10-05 | 2007-05-31 | Immunex Corp., Seattle | Als lerk6 bezeichnetes cytokin |
| US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US6518061B1 (en) * | 1995-03-15 | 2003-02-11 | The United States Of America As Represented By The Department Of Health And Human Services | IL-13 receptor specific chimeric proteins and uses thereof |
| US5869046A (en) * | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5714586A (en) * | 1995-06-07 | 1998-02-03 | American Cyanamid Company | Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| US5712374A (en) * | 1995-06-07 | 1998-01-27 | American Cyanamid Company | Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates |
| US6267958B1 (en) * | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| US6911530B1 (en) * | 1995-10-23 | 2005-06-28 | Amrad Operations, Pty., Ltd. | Haemopoietin receptor and genetic sequences encoding same |
| DE19544393A1 (de) | 1995-11-15 | 1997-05-22 | Hoechst Schering Agrevo Gmbh | Synergistische herbizide Mischungen |
| US5916771A (en) | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| EP1017807A1 (en) * | 1997-05-29 | 2000-07-12 | Board Of Regents The University Of Texas System | Osf2/cbfa1 compositions and methods of use |
| US6171586B1 (en) * | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| EP1000084A4 (en) * | 1997-07-08 | 2003-03-26 | Human Genome Sciences Inc | 123 HUMAN SECRETED PROTEINS |
| US6040498A (en) * | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| US6610833B1 (en) * | 1997-11-24 | 2003-08-26 | The Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
| US6194551B1 (en) * | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| US6482403B1 (en) * | 1998-05-29 | 2002-11-19 | Heska Corporation | Caniney IL-13 immunoregulatory proteins and uses thereof |
| US6737056B1 (en) * | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| PL209392B1 (pl) * | 1999-01-15 | 2011-08-31 | Genentech Inc | Przeciwciało, komórka gospodarza, sposób wytwarzania przeciwciała oraz zastosowanie przeciwciała |
| WO2000044407A2 (en) * | 1999-02-01 | 2000-08-03 | Amgen Canada | Materials and methods to inhibit hodgkin and reed sternberg cell growth |
| ES2248127T3 (es) * | 1999-10-04 | 2006-03-16 | Medicago Inc. | Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno. |
| EP1240319A1 (en) * | 1999-12-15 | 2002-09-18 | Genentech, Inc. | Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| US7439064B2 (en) * | 2000-03-09 | 2008-10-21 | Wicell Research Institute, Inc. | Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium |
| JP2003531588A (ja) * | 2000-04-11 | 2003-10-28 | ジェネンテック・インコーポレーテッド | 多価抗体とその用途 |
| KR20030069989A (ko) * | 2000-09-08 | 2003-08-27 | 다이이찌 산토리 파마 가부시키가이샤 | 심부전 치료제 |
| US6946292B2 (en) * | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US6596541B2 (en) * | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| CA2430013C (en) * | 2000-11-30 | 2011-11-22 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
| PT2000545E (pt) * | 2001-06-20 | 2011-12-21 | Genentech Inc | Composições e métodos para o diagnóstico e tratamento do tumor pulmonar |
| US7803915B2 (en) * | 2001-06-20 | 2010-09-28 | Genentech, Inc. | Antibody compositions for the diagnosis and treatment of tumor |
| US20050107595A1 (en) * | 2001-06-20 | 2005-05-19 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| US7384736B2 (en) * | 2001-09-06 | 2008-06-10 | Decode Genetics Ehf. | Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
| WO2003038055A2 (en) * | 2001-10-31 | 2003-05-08 | Mds Proteomics, Inc. | Proteins involved in regulation of adipocytes and uses related thereto |
| US20040093621A1 (en) * | 2001-12-25 | 2004-05-13 | Kyowa Hakko Kogyo Co., Ltd | Antibody composition which specifically binds to CD20 |
| EP1500400A4 (en) * | 2002-04-09 | 2006-10-11 | Kyowa Hakko Kogyo Kk | MEDICAMENT WITH ANTIBODY COMPOSITION |
| ATE503829T1 (de) * | 2002-04-09 | 2011-04-15 | Kyowa Hakko Kirin Co Ltd | Zelle mit erniedrigter oder deletierter aktivität eines am gdp-fucosetransport beteiligten proteins |
| BR0309145A (pt) * | 2002-04-09 | 2005-02-01 | Kyowa Hakko Kogyo Kk | Células das quais o genoma é modificado |
| EP1498490A4 (en) * | 2002-04-09 | 2006-11-29 | Kyowa Hakko Kogyo Kk | PROCESS FOR PREPARING ANTIBODY COMPOSITION |
| CA2488441C (en) * | 2002-06-03 | 2015-01-27 | Genentech, Inc. | Synthetic antibody phage libraries |
| JP2004121218A (ja) | 2002-08-06 | 2004-04-22 | Jenokkusu Soyaku Kenkyusho:Kk | 気管支喘息または慢性閉塞性肺疾患の検査方法 |
| US7361740B2 (en) * | 2002-10-15 | 2008-04-22 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| WO2004065416A2 (en) * | 2003-01-16 | 2004-08-05 | Genentech, Inc. | Synthetic antibody phage libraries |
| US20060104968A1 (en) * | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| AU2004229501B2 (en) * | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
| EP1628679A2 (en) * | 2003-05-23 | 2006-03-01 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumors of glial origin |
| WO2004106495A2 (en) * | 2003-05-29 | 2004-12-09 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| EP2327795B1 (en) * | 2003-06-10 | 2017-08-09 | The Trustees Of Boston University | Detection methods for disorders of the lung |
| GB0407315D0 (en) * | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| US9296820B2 (en) * | 2003-11-05 | 2016-03-29 | Roche Glycart Ag | Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function |
| EP2478912B1 (en) * | 2003-11-06 | 2016-08-31 | Seattle Genetics, Inc. | Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy |
| PL3718564T3 (pl) * | 2003-12-23 | 2024-03-18 | Genentech, Inc. | Nowe przeciwciała anty-IL 13 i ich zastosowania |
| EP1740615B1 (en) * | 2004-03-31 | 2014-11-05 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| US7501121B2 (en) * | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| KR100635540B1 (ko) * | 2004-10-12 | 2006-10-18 | 경북대학교 산학협력단 | 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물 |
| WO2006124451A2 (en) | 2005-05-11 | 2006-11-23 | Centocor, Inc. | Anti-il-13 antibodies, compositions, methods and uses |
| AU2006296399B2 (en) | 2005-09-30 | 2011-01-20 | Medimmune Limited | Interleukin-13 antibody composition |
| WO2007045477A2 (en) | 2005-10-21 | 2007-04-26 | Novartis Ag | Human antibodies against il-13 and therapeutic uses |
| US8017119B2 (en) * | 2005-12-28 | 2011-09-13 | Daiichi Sankyo Company, Ltd. | Antibody against periostin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periostin is involved |
| EP2441838A3 (en) * | 2006-01-24 | 2013-07-10 | Domantis Limited | Fusion proteins that contain natural junctions |
| EP1987359B1 (en) * | 2006-02-22 | 2015-03-18 | Philogen S.p.A. | Vascular tumor markers |
| WO2008027236A2 (en) * | 2006-08-30 | 2008-03-06 | Genentech, Inc. | Multispecific antibodies |
| JP4369468B2 (ja) * | 2006-12-15 | 2009-11-18 | 日本分光株式会社 | 不可逆反応測定方法 |
| WO2008083695A1 (de) | 2006-12-20 | 2008-07-17 | Patent-Treuhand-Gesellschaft für elektrische Glühlampen mbH | Vorrichtung und verfahren zur messung der intensität des lichtes einer ersten gruppe von lichtquellen einer beleuchtungseinheit |
| SI2132230T1 (sl) | 2007-03-22 | 2014-07-31 | Genentech, Inc. | Apoptotska protitelesa, ki veĹľejo membransko-vezan IgE |
| US8138056B2 (en) * | 2009-07-03 | 2012-03-20 | International Business Machines Corporation | Thermally insulated phase change material memory cells with pillar structure |
| RU2578468C2 (ru) * | 2010-12-16 | 2016-03-27 | Дженентек, Инк. | Способы диагностики и лечения, связанные с ингибированием th2 |
| UA117608C2 (uk) * | 2014-02-21 | 2018-08-27 | Дженентек, Інк. | Спосіб лікування еозинофільного захворювання у пацієнта шляхом застосування біспецифічного анти-il-13/il-17 антитіла |
| JP7231326B2 (ja) * | 2014-11-10 | 2023-03-01 | ジェネンテック， インコーポレイテッド | Ｉｌ－３３媒介性障害のための治療及び診断方法 |
-
2009
- 2009-03-31 BR BRPI0906261-0A patent/BRPI0906261A2/pt not_active Application Discontinuation
- 2009-03-31 EP EP13162396.9A patent/EP2631302A3/en not_active Withdrawn
- 2009-03-31 MX MX2010010746A patent/MX348362B/es active IP Right Grant
- 2009-03-31 RU RU2010144502A patent/RU2607569C2/ru active
- 2009-03-31 NZ NZ588853A patent/NZ588853A/xx not_active IP Right Cessation
- 2009-03-31 KR KR1020177014832A patent/KR102070761B1/ko not_active Expired - Fee Related
- 2009-03-31 AU AU2009231733A patent/AU2009231733B2/en not_active Ceased
- 2009-03-31 NZ NZ601815A patent/NZ601815A/en not_active IP Right Cessation
- 2009-03-31 JP JP2011503115A patent/JP6161233B2/ja not_active Expired - Fee Related
- 2009-03-31 SG SG2014014138A patent/SG2014014138A/en unknown
- 2009-03-31 WO PCT/US2009/039033 patent/WO2009124090A1/en not_active Ceased
- 2009-03-31 CN CN2009801200483A patent/CN102232113A/zh active Pending
- 2009-03-31 CA CA2718120A patent/CA2718120A1/en not_active Abandoned
- 2009-03-31 CN CN202011243211.XA patent/CN112481367A/zh active Pending
- 2009-03-31 EP EP09726775.1A patent/EP2271770B1/en active Active
- 2009-03-31 US US12/935,822 patent/US20110123530A1/en not_active Abandoned
- 2009-03-31 KR KR1020107024375A patent/KR20100131003A/ko not_active Ceased
-
2010
- 2010-10-03 IL IL208366A patent/IL208366A0/en active IP Right Grant
-
2014
- 2014-03-18 RU RU2014110413/10A patent/RU2014110413A/ru not_active Application Discontinuation
- 2014-05-23 JP JP2014107421A patent/JP6037515B2/ja not_active Expired - Fee Related
-
2015
- 2015-04-08 JP JP2015079581A patent/JP2015166738A/ja active Pending
-
2018
- 2018-01-04 PH PH12018500045A patent/PH12018500045A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2607569C2 (ru) | 2017-01-10 |
| AU2009231733B2 (en) | 2015-12-24 |
| SG2014014138A (en) | 2014-07-30 |
| MX2010010746A (es) | 2010-10-15 |
| IL208366A0 (en) | 2010-12-30 |
| JP2011523350A (ja) | 2011-08-11 |
| JP6037515B2 (ja) | 2016-12-07 |
| JP2014204725A (ja) | 2014-10-30 |
| NZ588853A (en) | 2013-07-26 |
| RU2014110413A (ru) | 2015-09-27 |
| CN112481367A (zh) | 2021-03-12 |
| CN102232113A (zh) | 2011-11-02 |
| MX348362B (es) | 2017-06-07 |
| KR102070761B1 (ko) | 2020-01-29 |
| EP2271770A1 (en) | 2011-01-12 |
| EP2271770B1 (en) | 2018-08-22 |
| JP2015166738A (ja) | 2015-09-24 |
| CA2718120A1 (en) | 2009-10-08 |
| PH12018500045A1 (en) | 2019-10-28 |
| AU2009231733A1 (en) | 2009-10-08 |
| NZ601815A (en) | 2014-10-31 |
| KR20100131003A (ko) | 2010-12-14 |
| KR20170063996A (ko) | 2017-06-08 |
| RU2010144502A (ru) | 2012-05-10 |
| EP2631302A3 (en) | 2014-01-08 |
| WO2009124090A1 (en) | 2009-10-08 |
| JP6161233B2 (ja) | 2017-07-12 |
| EP2631302A2 (en) | 2013-08-28 |
| US20110123530A1 (en) | 2011-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0906261A2 (pt) | "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente" | |
| BRPI0906903A2 (pt) | ''anticorpo kit de diagnóstico, método de detecção da expressão de cd70 em uma amostra de tecido, método para prognosticar, determinar um protocolo de tratamento ou monitorar o tratamento, uso de um agente de ligação a cd70 e combinação de um kit de diagnóstico e um kit farmacêutico | |
| EP2134855A4 (en) | USES OF FANCI AND FANCI MODULATING AGENTS IN PROGNOSIS, DIAGNOSIS AND CANCER THERAPY | |
| EP2076172A4 (en) | USE OF COHERENT RAMAN PROCEDURES FOR MEDICAL DIAGNOSTIC AND THERAPEUTIC PURPOSES AND CALIBRATION METHOD THEREFOR | |
| EP2200548A4 (en) | FLUID FLOW DEVICE AND METHOD FOR DIAGNOSING OR THERAPY OF TISSUE | |
| BRPI1006733A2 (pt) | kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método | |
| EP3865135A3 (en) | Neuroactive steroids for use in therapy | |
| PL2294582T3 (pl) | Urządzenie i sposób wytwarzania izotopów medycznych | |
| BRPI0807927A2 (pt) | Métodos para determinar uma susceptibilidade a doença cardiovascular em um indivíduo humano, de identificação de um marcador para uso para avaliar susceptibilidade a doença cardiovascular, para genotipar uma amostra de ácido nucleico, para avaliar um indivíduo para probabilidade de resposta a um agente terapêutico, para predizer prognóstico de um indivíduo diagnosticado com doença cardiovascular, e para monitorar progresso de tratamento de um indivíduo passando por tratamento para doença cardiovascular, kit para avaliar susceptibilidade a doença cardiovascular em um indivíduo humano, uso de uma sonda de oligonucleotídeo, meio legível por computador, e, aparelho para determinar um indicador genético para doença cardiovascular em um indivíduo humano | |
| HRP20190031T1 (hr) | Sintetski triterpenoidi i postupci njihove upotrebe u liječenju bolesti | |
| DE602007010480D1 (de) | Blutsensor und diesen enthaltendes blutuntersuchungsinstrument | |
| EP2222355A4 (en) | INTRADUCTAL DIAGNOSTIC AND THERAPEUTIC PROCEDURES FOR THE MEIBOMINE AND RELEVANT DEVICE | |
| BRPI0912292A2 (pt) | composições e métodos para o uso de células no tratamento do tecido cardíaco. | |
| EP2240077A4 (en) | SYSTEM AND METHOD FOR COSMETIC ANALYSIS AND TREATMENT DIAGNOSIS | |
| BR112013002441A2 (pt) | uso de um anticorpo anti-cd20 afucosilado, composição e método de tratamento de paciente que sofre de câncer | |
| BR112015013374A2 (pt) | dispositivo de luva hemostática e método para uso do mesmo | |
| ZA201007005B (en) | Methods of diagnosing, preventing and treating bone mass diseases | |
| SI2170877T1 (sl) | Substutuirani (oksazolidinon-5-il-metil)-2-tiofen-karboksamidi in njihova uporaba na področju koagulacije krvi | |
| EP1989216A4 (en) | DIAGNOSIS AND TREATMENT OF PROSTATE CANCER | |
| BRPI0909563A2 (pt) | biomaterial, método de produção do biomaterial, uso do biomaterial e mpetodo de tratamento de lesões de tecidos em pacientes | |
| WO2010127057A3 (en) | Biomarkers of therapeutic responsiveness | |
| WO2009122444A3 (en) | Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof | |
| CL2007003484A1 (es) | Composicion farmaceutica que comprende valsartan y un tensoactivo, un componente lipofilico y un componente hidrofilico; procedimiento de preparacion; y uso en el tratamiento de la insuficiencia cardiaca, angina, infarto de miocardio, arterioescleros | |
| PT2106808T (pt) | Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico | |
| WO2009022988A3 (en) | Vhz for diagnosis and treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |